Lutetium-labelled peptides for therapy of neuroendocrine tumours

Treatment with radiolabelled somatostatin analogues is a promising new tool in the management of patients with inoperable or metastasized neuroendocrine tumours. Symptomatic improvement may occur with (177)Lu-labelled somatostatin analogues that have been used for peptide receptor radionuclide thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., Kwekkeboom, D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304065/
https://www.ncbi.nlm.nih.gov/pubmed/22388631
http://dx.doi.org/10.1007/s00259-011-2039-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304065/
https://www.ncbi.nlm.nih.gov/pubmed/22388631
http://dx.doi.org/10.1007/s00259-011-2039-y

Ejemplares similares